RESISTANCEPLUS

Serial Number 79182819
Registration 5220218
739

Registration Progress

Application Filed
Nov 30, 2015
Under Examination
Approved for Publication
Mar 28, 2017
Published for Opposition
Mar 28, 2017
Registered
Jun 13, 2017

Trademark Image

RESISTANCEPLUS

Basic Information

Serial Number
79182819
Registration Number
5220218
Filing Date
November 30, 2015
Registration Date
June 13, 2017
Published for Opposition
March 28, 2017
Drawing Code
5

Status Summary

Current Status
Active
Status Code
739
Status Date
Feb 21, 2024
Registration
Registered
Classes
001 005 010

Rights Holder

SpeeDx Pty Ltd

99
Address
Suite G16, National Innovation Centre
AustralianTechnology Park, 4 Cornwallis Street
Eveleigh NSW 2015
AU

Ownership History

SpeeDx Pty Ltd

Original Applicant
99
Eveleigh NSW 2015 AU

SpeeDx Pty Ltd

Owner at Publication
99
Eveleigh NSW 2015 AU

SpeeDx Pty Ltd

Original Registrant
99
Eveleigh NSW 2015 AU

Legal Representation

Attorney
Mainak H. Mehta

USPTO Deadlines

Next Deadline
592 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2017-06-13)
Due Date
June 13, 2027
Grace Period Ends
December 13, 2027

Application History

50 events
Date Code Type Description Documents
Oct 16, 2025 RNWL P INTERNATIONAL REGISTRATION RENEWED Loading...
Feb 22, 2024 NA75 E NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Loading...
Feb 21, 2024 C75A O REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. Loading...
Feb 12, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 6, 2023 ES75 I TEAS SECTION 71 & 15 RECEIVED Loading...
Jun 13, 2022 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Oct 28, 2017 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Sep 20, 2017 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Sep 20, 2017 FIMP P FINAL DISPOSITION PROCESSED Loading...
Sep 13, 2017 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 13, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 28, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 28, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 10, 2017 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Mar 8, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 22, 2017 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Feb 13, 2017 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 13, 2017 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 13, 2017 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 13, 2017 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 13, 2017 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 10, 2017 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Feb 7, 2017 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Feb 7, 2017 GNFR O FINAL REFUSAL E-MAILED Loading...
Feb 7, 2017 CNFR R FINAL REFUSAL WRITTEN Loading...
Feb 1, 2017 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Feb 1, 2017 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 1, 2017 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 1, 2017 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 1, 2017 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 1, 2017 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 23, 2017 LIME X LIMITATION FROM THE IB - REQUEST EXAM REVIEW Loading...
Dec 16, 2016 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Dec 8, 2016 LIMG M LIMITATION OF GOODS RECEIVED FROM IB Loading...
Sep 16, 2016 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Sep 16, 2016 GNFR O FINAL REFUSAL E-MAILED Loading...
Sep 16, 2016 CNFR R FINAL REFUSAL WRITTEN Loading...
Sep 15, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 15, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 10, 2016 ALIE A ASSIGNED TO LIE Loading...
Sep 2, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 19, 2016 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 2, 2016 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Mar 2, 2016 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 2, 2016 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 1, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 29, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 27, 2016 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Feb 23, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 22, 2016 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 001
Chemicals used in industry, science, photography; chemicals used in agriculture, horticulture and forestry except fungicides, herbicides, insecticides, and parasiticides; chemical reagents and reactants in this class for non-medical purposes; enzymes for industrial purposes, namely, for use in the biotechnology industry; nucleic acid sequences, other than medical and veterinary purposes; nucleic recombinant acids; acids, namely, inorganic acids; organic acids for use in the biotechnology industry; DNA polymerase, other than medical and veterinary purposes; chemicals used in food processing and screening; chemicals used in environmental monitoring
Class 005
Pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens for medical and veterinary purposes; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceutical, veterinary and medical purposes; medical kits in this class consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; diagnostic reagents for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
Class 010
Surgical, medical and veterinary apparatus and instruments, namely, surgical apparatus and instruments for medical or veterinary use; diagnostic testing apparatus and instruments for medical purposes, namely, for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; point of care medical devices for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; medical screening apparatus in this class for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy

Additional Information

Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
RESISTANCE PLUS

Classification

International Classes
001 005 010